{"id":"W2167355583","doi":"10.1016/s1470-2045(11)70150-4","title":"Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Clinical endpoint; Lymphoma; Oncology; Clinical trial; Surgery; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001064275,0.0007844082,0.003546779,0.0002939876,0.0002902671,0.00004266922,0.0004509276,0.0004934078,0.0003710532],"category_scores_gemma":[0.0005033579,0.0004644581,0.0004033895,0.000635319,0.0006074462,0.000228044,0.0001878592,0.0004547351,0.0004482662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001857334,"about_ca_system_score_gemma":0.001245397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001230822,"about_ca_topic_score_gemma":0.0007687646,"domain_scores_codex":[0.9949589,0.0008520586,0.00108424,0.001048339,0.0007333119,0.001323125],"domain_scores_gemma":[0.99628,0.001118288,0.0005868908,0.001291955,0.0003412945,0.0003815707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9167324,0.0590085,0.002743847,0.00006267176,0.001289377,0.003789862,0.001842071,0.000001879367,0.00001334406,0.0003510195,0.002972692,0.01119229],"study_design_scores_gemma":[0.9497417,0.02068808,0.01619615,0.0001823771,0.001696719,0.0001702568,0.0003586524,0.0001378223,0.0005354948,0.00008987387,0.009655544,0.0005473866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821003,0.0005151333,0.00005993026,0.001465771,0.001180671,0.00608382,0.0001590335,0.0001912148,0.008244143],"genre_scores_gemma":[0.9928522,0.0003488297,0.00252186,0.001566708,0.0007664821,0.00131529,0.0002972945,0.0001064519,0.0002249121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03832041,"threshold_uncertainty_score":0.9997807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05732662351427194,"score_gpt":0.3184787071032654,"score_spread":0.2611520835889935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}